Related Experiment Videos
Megestrol-induced clinical adrenal insufficiency
1Harvard Medical School Massachusetts General Hospital, Department of Obstetrics and Gynecology, Boston 02114, USA.
European Journal of Gynaecological Oncology
|June 8, 2000
Summary
Megestrol acetate can cause adrenal insufficiency by affecting the pituitary-adrenal axis. This condition may present with fatigue and hypotension, requiring careful diagnosis in patients using megestrol.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Megestrol acetate is a synthetic progestogen used in various clinical settings.
- Alterations in the hypothalamic-pituitary-adrenal (HPA) axis are potential side effects of certain medications.
Observation:
- A case study detailing a patient who developed Cushingoid features after megestrol acetate administration.
- The patient subsequently exhibited signs of adrenal insufficiency upon cessation of megestrol acetate therapy.
Findings:
- Megestrol acetate can induce significant abnormalities in the pituitary-adrenal axis.
- The patient's adrenal insufficiency was directly linked to megestrol acetate treatment.
Implications:
- Clinicians should consider megestrol-induced adrenal insufficiency in patients presenting with fatigue, hypotension, and asthenia.
- Awareness of this potential side effect is crucial for timely diagnosis and management in patients on megestrol acetate therapy.